Peijing Li
Hangzhou, 310022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Low dose radiotherapy-induced tumor-preferential antigens enhance antibody-drug conjugate efficacy in solid tumors.
Journal: Neoplasia (New York, N.Y.)
Published: May 21, 2026
Long-Term Outcomes of Concurrent Chemoradiotherapy With S-1 in Older Patients With Esophageal Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Journal: JAMA network open
Published: March 27, 2026
Epigenetic Reprogramming Potentiates ICAM1 Antibody Drug Conjugates in Preclinical Models of Melanoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 06, 2024
The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors.
Journal: Journal of hematology & oncology
Published: September 06, 2023
PI3K/mTOR inhibitors promote G6PD autophagic degradation and exacerbate oxidative stress damage to radiosensitize small cell lung cancer.
Journal: Cell death & disease
Published: April 17, 2023
PI3K/AKT/mTOR pathway, hypoxia, and glucose metabolism: Potential targets to overcome radioresistance in small cell lung cancer.
Journal: Cancer pathogenesis and therapy
Published: July 05, 2022
Efficacy of Concurrent Chemoradiotherapy With S-1 vs Radiotherapy Alone for Older Patients With Esophageal Cancer: A Multicenter Randomized Phase 3 Clinical Trial.
Journal: JAMA oncology
Published: August 05, 2021
Explore the Value of Adding Induction Chemotherapy to Concurrent Chemoradiotherapy in T3-4N0M0 Nasopharyngeal Carcinoma Patients: A Retrospective Study.
Journal: Cancer management and research
Published: May 28, 2021
The effectiveness of probiotics in prevention and treatment of cancer therapy-induced oral mucositis: A systematic review and meta-analysis.
Journal: Oral oncology
Published: August 14, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026